As many as 49 children have died during clinical trials of new medicines in the premier All India Institute of Medical Sciences in Delhi during the last two-and-a-half years. A total of 4,142......
B Markets extended losses on Wednesday and the Sensex ended below 27,000 for the second straight session weighed down by select index heavyweights even as oil and gas shares rebounded from their......
Drug firm Ranbaxy Laboratories on Monday reported a consolidated net profit of Rs 477.75 crore (Rs 4.77 billion)for the quarter ended September 30, 2014 on account of robust sales. The company had......
Shares of Ranbaxy Laboratories rose more than 5 per cent after the company announced a US regulatory approval for a hypertension drug to be launched by one of its subsidiaries. The stock rose by......
Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the US......
After its Paonta Sahib and Dewas units, Ranbaxy’s third and newly commissioned Mohali facility, too, appears to have come under the US regulator’s scanner. After finding deviations from......